Finally, the IgE isotype has only recently been implicated in taking part in MS pathology, as sera from some MS patients contain significantly higher levels of IgE reactive against myelin protein-derived peptides whereas peptide-reactive IgA or IgG is often undetectable (80). This evidence concerns the gene IGHE and myeloid sarcoma.